The Na+/I− symporter (NIS) mediates electroneutral active transport of the environmental pollutant perchlorate
- Orsolya Dohán*,†,
- Carla Portulano*,
- Cécile Basquin*,
- Andrea Reyna-Neyra‡,
- L. Mario Amzel§, and
- Nancy Carrasco*,¶
- Departments of *Molecular Pharmacology and
- ‡Neuroscience, Albert Einstein College of Medicine, Bronx, NY 10461; and
- §Department of Biophysics and Biophysical Chemistry, Johns Hopkins University School of Medicine, Baltimore, MD 21205
-
Edited by H. Ronald Kaback, University of California, Los Angeles, CA, and approved October 30, 2007 (received for review July 31, 2007)
Abstract
The Na+/I− symporter (NIS) is a key plasma membrane protein that mediates active I− uptake in the thyroid, lactating breast, and other tissues with an electrogenic stoichiometry of 2 Na+ per I−. In the thyroid, NIS-mediated I− uptake is the first step in the biosynthesis of the iodine-containing thyroid hormones, which are essential early in life for proper CNS development. In the lactating breast, NIS mediates the translocation of I− to the milk, thus supplying this essential anion to the nursing newborn. Perchlorate (ClO4 −) is a well known competitive inhibitor of NIS. Exposure to food and water contaminated with ClO4 − is common in the U.S. population, and the public health impact of such exposure is currently being debated. To date, it is still uncertain whether ClO4 − is a NIS blocker or a transported substrate of NIS. Here we show in vitro and in vivo that NIS actively transports ClO4 −, including ClO4 − translocation to the milk. A simple mathematical fluxes model accurately predicts the effect of ClO4 − transport on the rate and extent of I− accumulation. Strikingly, the Na+/ ClO4 − transport stoichiometry is electroneutral, uncovering that NIS translocates different substrates with different stoichiometries. That NIS actively concentrates ClO4 − in maternal milk suggests that exposure of newborns to high levels of ClO4 − may pose a greater health risk than previously acknowledged because ClO4 − would thus directly inhibit the newborns' thyroidal I− uptake.
Footnotes
- ¶To whom correspondence should be addressed. E-mail: carrasco{at}aecom.yu.edu
-
Author contributions: O.D. and C.P. contributed equally to this work; O.D., C.P., C.B., A.R.-N., L.M.A., and N.C. designed research; O.D., C.P., C.B., A.R.-N., L.M.A., and N.C. performed research; O.D., C.P., C.B., L.M.A., and N.C. analyzed data; and O.D., C.P., C.B., L.M.A., and N.C. wrote the paper.
-
↵ †Present address: National Institute of Oncology and Institute of Experimental Medicine, Hungarian Academy of Sciences, Rath Gyorgy u. 7–9, 1122 Budapest, Hungary.
-
The authors declare no conflict of interest.
-
This article is a PNAS Direct Submission.
-
This article contains supporting information online at www.pnas.org/cgi/content/full/0707207104/DC1.
-
Freely available online through the PNAS open access option.
- © 2007 by The National Academy of Sciences of the USA





